Creative Medical Technologies Has Received A Notice Of Allowance For A U.S. Patent Titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS"

Benzinga Newsdesk www.benzinga.com Neutral 94.0%

Neg 0% Neu 94% Pos 0%

https://x.com/PatentGrants/status/2085092646184497356

https://patentcenter.uspto.gov/applications/17931868/ifw/docs

Comments

No comments yet. Be the first!